Our client, an oncology biotech start-up, expected top-line results for their lead asset in the next two years. Given how critical it was to get the commercialization of this first asset right, the client team partnered with Acsel to determine requirements for successful commercialization, identify gaps in existing plans, and prepare a refined strategy.
Leveraging our experience guiding startups through the commercialization process for the first time, we:
In collaboration with the client team, Acsel crafted a tailored commercialization plan for the organization to execute. The insights gleaned from the benchmarking work, coupled with Acsel’s experience, led to development of a well-formulated and evidence-supported plan shared with Senior Leadership and the Board of Directors.